Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7735.00 | 7946.50 | 0.9734 | 0.9644 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7984.00 | 7946.50 | 1.0047 | 1.0063 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 4893.00 | 7946.50 | 0.6157 | 0.4477 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7998.00 | 7946.50 | 1.0065 | 1.0086 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 8012.00 | 7946.50 | 1.0082 | 1.0110 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 4071.00 | 7946.50 | 0.5123 | 0.2807 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 8078.00 | 7946.50 | 1.0165 | 1.0220 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 116.00 | 119.75 | 0.9687 | 0.9172 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 132.00 | 119.75 | 1.1023 | 1.2764 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 93.00 | 119.75 | 0.7766 | 0.4292 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 156.25 | 71.09 | 76.00 | 119.75 | 0.6347 | 0.0928 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 71.09 | 165.00 | 119.75 | 1.3779 | 2.0625 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 110.00 | 119.75 | 0.9186 | 0.7865 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 153.00 | 119.75 | 1.2777 | 1.7700 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 156.25 | 71.09 | 108.00 | 119.75 | 0.9019 | 0.7435 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 71.09 | 153.00 | 119.75 | 1.2777 | 1.7700 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 122.00 | 119.75 | 1.0188 | 1.0501 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 78.00 | 119.75 | 0.6514 | 0.1312 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 106.00 | 119.75 | 0.8852 | 0.7007 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 69.00 | 119.75 | 0.5762 | -0.0389 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 133.00 | 119.75 | 1.1106 | 1.2994 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 81.00 | 119.75 | 0.6764 | 0.1894 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 88.00 | 119.75 | 0.7349 | 0.3280 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 111.00 | 119.75 | 0.9269 | 0.8081 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 113.00 | 119.75 | 0.9436 | 0.8516 |